116 related articles for article (PubMed ID: 22195859)
1. Biodegradable polyesterurethanes with shape-memory properties for dexamethasone and aspirin controlled release.
Feng Y; Zhang S; Wang H; Zhao H; Lu J; Guo J; Behl M; Lendlein A
J Control Release; 2011 Nov; 152 Suppl 1():e21-3. PubMed ID: 22195859
[No Abstract] [Full Text] [Related]
2. Drug release from biodegradable polyesterurethanes with shape-memory effect.
Feng Y; Zhang S; Wang H; Zhao H; Lu J; Guo J; Behl M; Lendlein A
J Control Release; 2011 Nov; 152 Suppl 1():e20-1. PubMed ID: 22195852
[No Abstract] [Full Text] [Related]
3. Amino acid based polyesteramides and polyesterurethanes: cell responsive matrices for drug delivery.
Dias AA; Plum B; Mihov G; Turnell B
J Control Release; 2011 Nov; 152 Suppl 1():e10-1. PubMed ID: 22195777
[No Abstract] [Full Text] [Related]
4. Preparation and characterization of aspirin/chitosan nanoparticles by nucleation and ionic crosslinking in micro emulsions.
Jin S; Feng L; Yu X
J Control Release; 2011 Nov; 152 Suppl 1():e39-41. PubMed ID: 22195912
[No Abstract] [Full Text] [Related]
5. Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms.
Rattanakit P; Moulton SE; Santiago KS; Liawruangrath S; Wallace GG
Int J Pharm; 2012 Jan; 422(1-2):254-63. PubMed ID: 22101281
[TBL] [Abstract][Full Text] [Related]
6. A biodegradable filament for controlled drug delivery.
Mack BC; Wright KW; Davis ME
J Control Release; 2009 Nov; 139(3):205-11. PubMed ID: 19567255
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
8. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
[TBL] [Abstract][Full Text] [Related]
9. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
Kasperczyk J; Stoklosa K; Dobrzynski P; Stepien K; Kaczmarczyk B; Dzierzega-Lecznar A
Int J Pharm; 2009 Dec; 382(1-2):124-9. PubMed ID: 19715746
[TBL] [Abstract][Full Text] [Related]
10. Controlled heparin release from electrospun gelatin fibers.
Wang H; Feng Y; Zhao H; Lu J; Guo J; Behl M; Lendlein A
J Control Release; 2011 Nov; 152 Suppl 1():e28-9. PubMed ID: 22195905
[No Abstract] [Full Text] [Related]
11. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
[TBL] [Abstract][Full Text] [Related]
12. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
13. Long acting porous microparticle for pulmonary protein delivery.
Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
[TBL] [Abstract][Full Text] [Related]
14. Controlled release of hydrogel modified textile products.
Hu J
J Control Release; 2011 Nov; 152 Suppl 1():e31-3. PubMed ID: 22195907
[No Abstract] [Full Text] [Related]
15. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
16. Effect of drug type on the degradation rate of PLGA matrices.
Siegel SJ; Kahn JB; Metzger K; Winey KI; Werner K; Dan N
Eur J Pharm Biopharm; 2006 Nov; 64(3):287-93. PubMed ID: 16949804
[TBL] [Abstract][Full Text] [Related]
17. Keratin films from chicken feathers for controlled drug release.
Li FY; Wang RM; He YF; Li XX; Song PF; Ying XC; Mao CW
J Control Release; 2011 Nov; 152 Suppl 1():e92-3. PubMed ID: 22195951
[No Abstract] [Full Text] [Related]
18. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
Klose D; Delplace C; Siepmann J
Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
[TBL] [Abstract][Full Text] [Related]
19. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
Doan TV; Olivier JC
Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
Cai J; Zhang Y; Du W; Nan K
J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
[No Abstract] [Full Text] [Related]
[Next] [New Search]